Report Detail
Global Hydroxyzine Imine Market Size, Status and Forecast 2019-2025
- RnM2700429 |
- 25 June, 2019 |
- Global |
- 93 Pages |
- QYResearch |
- Other
Hydroxyzine imine are medications which are intended for an organic disease state when it manifests through anxiety. Hydroxyzine imine is a drug that attenuates activity in the central nervous system. This property aids hydroxyzine imine to treat anxiety and tension associated with psychoneurosis. Besides, it also acts as an antihistamine which reduces the actions of natural histamine in the body and hence can cure symptoms of itching, or hives on the skin.
It is also used along with other medications given during and after general anesthesia to produce synergistic effects. Key factors driving the growth of this market are the increase in population with allergic reactions coupled with rise in geriatric population.
In 2018, the global Hydroxyzine Imine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hydroxyzine Imine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hydroxyzine Imine development in United States, Europe and China.
The key players covered in this study
Pfizer Inc.
GlaxoSmithKline plc
Teva Pharmaceutical Industries
Shanghai Ruizheng Chemical Technology Co., Ltd
Lupin Pharmaceuticals, Inc.
N&R Industries
OAK PHARMS INC.
Changzhou ComWin Fine Chemicals Co., Ltd
Novartis International AG
Impax Laboratories, Inc
Market segment by Type, the product can be split into
Tablet
Capsule
Syrup
Injection
Market segment by Application, split into
Urticaria
Histamine-Mediated Pruritus and Atopic
Contact Dermatoses
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hydroxyzine Imine status, future forecast, growth opportunity, key market and key players.
To present the Hydroxyzine Imine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hydroxyzine Imine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Hydroxyzine Imine Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Tablet
- 1.4.3 Capsule
- 1.4.4 Syrup
- 1.4.5 Injection
- 1.5 Market by Application
- 1.5.1 Global Hydroxyzine Imine Market Share by Application (2014-2025)
- 1.5.2 Urticaria
- 1.5.3 Histamine-Mediated Pruritus and Atopic
- 1.5.4 Contact Dermatoses
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Hydroxyzine Imine Market Size
- 2.2 Hydroxyzine Imine Growth Trends by Regions
- 2.2.1 Hydroxyzine Imine Market Size by Regions (2014-2025)
- 2.2.2 Hydroxyzine Imine Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Hydroxyzine Imine Market Size by Manufacturers
- 3.1.1 Global Hydroxyzine Imine Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Hydroxyzine Imine Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Hydroxyzine Imine Market Concentration Ratio (CR5 and HHI)
- 3.2 Hydroxyzine Imine Key Players Head office and Area Served
- 3.3 Key Players Hydroxyzine Imine Product/Solution/Service
- 3.4 Date of Enter into Hydroxyzine Imine Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Hydroxyzine Imine Market Size by Type (2014-2019)
- 4.2 Global Hydroxyzine Imine Market Size by Application (2014-2019)
5 United States
- 5.1 United States Hydroxyzine Imine Market Size (2014-2019)
- 5.2 Hydroxyzine Imine Key Players in United States
- 5.3 United States Hydroxyzine Imine Market Size by Type
- 5.4 United States Hydroxyzine Imine Market Size by Application
6 Europe
- 6.1 Europe Hydroxyzine Imine Market Size (2014-2019)
- 6.2 Hydroxyzine Imine Key Players in Europe
- 6.3 Europe Hydroxyzine Imine Market Size by Type
- 6.4 Europe Hydroxyzine Imine Market Size by Application
7 China
- 7.1 China Hydroxyzine Imine Market Size (2014-2019)
- 7.2 Hydroxyzine Imine Key Players in China
- 7.3 China Hydroxyzine Imine Market Size by Type
- 7.4 China Hydroxyzine Imine Market Size by Application
8 Japan
- 8.1 Japan Hydroxyzine Imine Market Size (2014-2019)
- 8.2 Hydroxyzine Imine Key Players in Japan
- 8.3 Japan Hydroxyzine Imine Market Size by Type
- 8.4 Japan Hydroxyzine Imine Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Hydroxyzine Imine Market Size (2014-2019)
- 9.2 Hydroxyzine Imine Key Players in Southeast Asia
- 9.3 Southeast Asia Hydroxyzine Imine Market Size by Type
- 9.4 Southeast Asia Hydroxyzine Imine Market Size by Application
10 India
- 10.1 India Hydroxyzine Imine Market Size (2014-2019)
- 10.2 Hydroxyzine Imine Key Players in India
- 10.3 India Hydroxyzine Imine Market Size by Type
- 10.4 India Hydroxyzine Imine Market Size by Application
11 Central & South America
- 11.1 Central & South America Hydroxyzine Imine Market Size (2014-2019)
- 11.2 Hydroxyzine Imine Key Players in Central & South America
- 11.3 Central & South America Hydroxyzine Imine Market Size by Type
- 11.4 Central & South America Hydroxyzine Imine Market Size by Application
12 International Players Profiles
- 12.1 Pfizer Inc.
- 12.1.1 Pfizer Inc. Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Hydroxyzine Imine Introduction
- 12.1.4 Pfizer Inc. Revenue in Hydroxyzine Imine Business (2014-2019)
- 12.1.5 Pfizer Inc. Recent Development
- 12.2 GlaxoSmithKline plc
- 12.2.1 GlaxoSmithKline plc Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Hydroxyzine Imine Introduction
- 12.2.4 GlaxoSmithKline plc Revenue in Hydroxyzine Imine Business (2014-2019)
- 12.2.5 GlaxoSmithKline plc Recent Development
- 12.3 Teva Pharmaceutical Industries
- 12.3.1 Teva Pharmaceutical Industries Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Hydroxyzine Imine Introduction
- 12.3.4 Teva Pharmaceutical Industries Revenue in Hydroxyzine Imine Business (2014-2019)
- 12.3.5 Teva Pharmaceutical Industries Recent Development
- 12.4 Shanghai Ruizheng Chemical Technology Co., Ltd
- 12.4.1 Shanghai Ruizheng Chemical Technology Co., Ltd Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Hydroxyzine Imine Introduction
- 12.4.4 Shanghai Ruizheng Chemical Technology Co., Ltd Revenue in Hydroxyzine Imine Business (2014-2019)
- 12.4.5 Shanghai Ruizheng Chemical Technology Co., Ltd Recent Development
- 12.5 Lupin Pharmaceuticals, Inc.
- 12.5.1 Lupin Pharmaceuticals, Inc. Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Hydroxyzine Imine Introduction
- 12.5.4 Lupin Pharmaceuticals, Inc. Revenue in Hydroxyzine Imine Business (2014-2019)
- 12.5.5 Lupin Pharmaceuticals, Inc. Recent Development
- 12.6 N&R Industries
- 12.6.1 N&R Industries Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Hydroxyzine Imine Introduction
- 12.6.4 N&R Industries Revenue in Hydroxyzine Imine Business (2014-2019)
- 12.6.5 N&R Industries Recent Development
- 12.7 OAK PHARMS INC.
- 12.7.1 OAK PHARMS INC. Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Hydroxyzine Imine Introduction
- 12.7.4 OAK PHARMS INC. Revenue in Hydroxyzine Imine Business (2014-2019)
- 12.7.5 OAK PHARMS INC. Recent Development
- 12.8 Changzhou ComWin Fine Chemicals Co., Ltd
- 12.8.1 Changzhou ComWin Fine Chemicals Co., Ltd Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Hydroxyzine Imine Introduction
- 12.8.4 Changzhou ComWin Fine Chemicals Co., Ltd Revenue in Hydroxyzine Imine Business (2014-2019)
- 12.8.5 Changzhou ComWin Fine Chemicals Co., Ltd Recent Development
- 12.9 Novartis International AG
- 12.9.1 Novartis International AG Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Hydroxyzine Imine Introduction
- 12.9.4 Novartis International AG Revenue in Hydroxyzine Imine Business (2014-2019)
- 12.9.5 Novartis International AG Recent Development
- 12.10 Impax Laboratories, Inc
- 12.10.1 Impax Laboratories, Inc Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Hydroxyzine Imine Introduction
- 12.10.4 Impax Laboratories, Inc Revenue in Hydroxyzine Imine Business (2014-2019)
- 12.10.5 Impax Laboratories, Inc Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Hydroxyzine Imine . Industry analysis & Market Report on Hydroxyzine Imine is a syndicated market report, published as Global Hydroxyzine Imine Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Hydroxyzine Imine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
